Delivery Order SPE2DB20D9331-SPE2DB24FL1G8

Award Date 6/21/24
Potential Completion Date 7/15/24
Potential Value $31K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $45,943.92 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4564357709 ADCETRIS 50 MG VIALS. This Delivery Order contract is part of a larger single-award Indefinite Delivery Contract (IDC) between the DLA and DMS Pharmaceutical Group valued at up to $499,999,999, which runs through December 31, 2025. The IDC...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $15,314.66 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of ADCETRIS 50 MG VIALS, a specialized pharmaceutical product, to support the medical needs of military healthcare facilities. This contract is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, which enables the...
The U.S. government's Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $15,314.66 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which does not have a set-aside designation, is for the delivery of ADCETRIS 50 MG VIALS to support the medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $68,915.88 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group to provide a comprehensive range of pharmaceutical products and medical supplies, including branded and generic prescription...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $61,258.56 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of 50 mg vials of the pharmaceutical drug ADCETRIS, with a period of performance through December 27, 2024. This delivery order is issued under DMS Pharmaceutical Group's existing $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $91,887.84 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Adcetris 50 mg vials, a specialized oncology medication. This delivery order is issued under a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and DLA, which allows the agency to place orders for a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $61,258.56 firm fixed-price contract is for the procurement of ADCETRIS 50 MG vials, with a period of performance through May 22, 2024. DMS Pharmaceutical Group holds a single-award, indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the agency to issue delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $30,629.28 contract is for the delivery of ADCETRIS 50 MG VIALS, a specialty oncology medication. The award is part of DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business in Park Ridge, Illinois. The $45,943.92 contract is for the delivery of ADCETRIS 50 MG VIALS, with a completion date of February 20, 2024. The contract is issued against DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with the Defense Logistics Agency, valued at up to $4,999,999 through 2025. This...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $45,943.92, is for the delivery of ADCETRIS 50 MG VIALS, a specialty oncology medication. DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November...
  • SPE2DB20D9331
    Indefinite Delivery Contract
  • SPE2DB20D9331-SPE2DB24FL1G8
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $30,629.28, is for the delivery of ADCETRIS 50 MG vials, a specialty oncology medication. This delivery order is part of a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. The IDC allows DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the diverse medical needs of military personnel and their dependents across various Department of Defense healthcare facilities. The contract does not have a set-aside designation.

Generated 1/9/25, 9:20 AM